Department of Surgical Sciences, School of Medicine, University of Rome Tor Vergata, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2013 Jan;17(1):130-3.
This is a prospective randomized study to analyze results obtained in two groups of patients affected of grade II hemorrhoids and treated with Radiofrequency Coagulation (RFC) or Combined Hemorrhoidal Radiocoagulation (CHR).
The study comprehended 30 patients of which 27 had at least 6 months of follow-up. Two groups of patients were considered: group A, represented by 12 individuals treated with RFC, and group B, consisting of 15 patients treated with CHR. Our purpose was to determine: grade of pain felt immediately after procedure and at first evacuation (score from 1 to 10), bleeding, patient's satisfaction 15 days and 6 months after treatment (score from 1 to 10) and incidence of failures.
Mean pain score reported immediately after procedure was 2.08 ± 0.9 for group A and 2.40 ± 1.5 for group B (p = NS). At first evacuation, mean pain score for group A and for group B was 2.16 ± 1.1 vs 2.33 ± 1.17, respectively (p = NS). Satisfaction score during first 15 days was 6.75 ± 2.76 for patients treated with RFC and 6.08 ± 2.20 for patients who received CHR (p = NS), while mean score of overall satisfaction after 6 months was 6.33 ± 1.96 (group A) vs 7.83 ± 2.05 (group B) (p < 0.05). At 6 months of follow-up, we observed 8 patients free from pain in group A (66.7%) and 13 patients in group B (86.7%).
Results reported in both groups of patients confirm validity and efficacy of the two techniques used in this study, even if later in time CHR showed better results than RFC.
这是一项前瞻性随机研究,旨在分析接受射频凝固(RFC)或联合痔放射凝固(CHR)治疗的 II 度痔患者的两组结果。
该研究纳入了 30 名患者,其中 27 名患者有至少 6 个月的随访。将患者分为两组:A 组 12 例,接受 RFC 治疗;B 组 15 例,接受 CHR 治疗。我们的目的是确定:术后即刻和首次排便时的疼痛程度(评分 1-10 分)、出血、治疗后 15 天和 6 个月的患者满意度(评分 1-10 分)和失败发生率。
A 组和 B 组术后即刻疼痛评分分别为 2.08 ± 0.9 和 2.40 ± 1.5(p = NS)。首次排便时,A 组和 B 组的疼痛评分分别为 2.16 ± 1.1 和 2.33 ± 1.17(p = NS)。RFC 治疗的患者在治疗后 15 天的满意度评分为 6.75 ± 2.76,接受 CHR 的患者为 6.08 ± 2.20(p = NS),而 6 个月时的总体满意度评分为 6.33 ± 1.96(A 组)和 7.83 ± 2.05(B 组)(p < 0.05)。在 6 个月的随访中,A 组 8 例(66.7%)患者无疼痛,B 组 13 例(86.7%)患者无疼痛。
两组患者的结果均证实了本研究中使用的两种技术的有效性和疗效,尽管 CHR 在后期显示出优于 RFC 的效果。